tradingkey.logo

Dr Reddy's kicks off India big pharma earnings with profit miss

ReutersJul 23, 2025 11:10 AM

- Indian generic drugs maker Dr Reddy's Laboratories REDY.NS missed quarterly profit expectations on Wednesday, as it struggled with pricing pressure on drugs and stiff competition in its key North America market.

The company's consolidated net profit increased to 14.18 billion rupees ($164.2 million) in the quarter ended June 30, below analysts' estimate of 14.94 billion rupees, as per data compiled by LSEG.

($1 = 86.3800 Indian rupees)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI